Skip to content

Metabolic phenotype in COPD

Metabolic phenotype characterization of inflammatory cells in smoking and non-smoking COPD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/01/011441
Enrollment
75
Registered
2018-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

None listed

Sponsors

Chest Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ï?· Healthy non-smoker o Be at least 40 years of age o Provide written informed consent o Never smoker and not exposed to biomass for >10 years o No major abnormality on clinical examination o Normal spirometry, FEV1/FVC >0.70 ï?· Healthy smoker o Be at least 40 years of age o Provide written informed consent o Be smoking tobacco in the form of bidi or cigarettes for at least 10 pack years o No major abnormality on clinical examination o Normal spirometry, FEV1/FVC >0.70 4 ï?· Healthy Biomass user o Be at least 40 years of age o Provide written informed consent o Be exposed to biomass for at least 10 fuel-years (exposure of 2hrs/day for 10 years) after adulthood o No major abnormality on clinical examination o Normal spirometry, FEV1/FVC >0.70 ï?· Tobacco smoking COPD o Be at least 40 years of age o Provide written informed consent o Be smoking tobacco in the form or bidi or cigarettes for at least 10 pack-years o Have a clinical diagnosis of COPD (GOLD stage I to III) and post-bronchodilator FEV1/FVC ratio ï?· Non-smoking COPD o Be at least 40 years of age o Provide written informed consent o Be exposed to biomass for at least 10 fuel-years after adulthood o Have a clinical diagnosis of COPD (GOLD stage I to III): post-bronchodilator FEV1/FVC ratio o Never smoker o FEV1 reversibility <400 mL to rule out asthma

Exclusion criteria

Exclusion criteria: Severe COPD patients would be excluded as the process of sputum induction may worsen their condition ï?· History of lung condition other than COPD including respiratory infectious diseases like tuberculosis, asthma, interstitial lung disease, etc

Design outcomes

Primary

MeasureTime frame
Mitochondrial respiration in PBMCs of healthy and COPD patientsTimepoint: 1

Secondary

MeasureTime frame
NoneTimepoint: 1

Countries

India

Contacts

Public ContactAmit Agarwal

Chest Research Foundation

aagarwal@crfindia.com2049134355

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 2, 2026